DK1504125T3 - Humant fedmemodtagelighedsgen og anvendelser deraf - Google Patents

Humant fedmemodtagelighedsgen og anvendelser deraf

Info

Publication number
DK1504125T3
DK1504125T3 DK03730032T DK03730032T DK1504125T3 DK 1504125 T3 DK1504125 T3 DK 1504125T3 DK 03730032 T DK03730032 T DK 03730032T DK 03730032 T DK03730032 T DK 03730032T DK 1504125 T3 DK1504125 T3 DK 1504125T3
Authority
DK
Denmark
Prior art keywords
obesity
gene
diagnosis
prevention
treatment
Prior art date
Application number
DK03730032T
Other languages
English (en)
Inventor
Peter Brooks
Anne Philippi
Joerg Hager
Elke Roschmann
Original Assignee
Integragen Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP02291201A external-priority patent/EP1362926A1/en
Priority claimed from EP20020292392 external-priority patent/EP1403380A1/en
Application filed by Integragen Sa filed Critical Integragen Sa
Application granted granted Critical
Publication of DK1504125T3 publication Critical patent/DK1504125T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Child & Adolescent Psychology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK03730032T 2002-05-15 2003-05-14 Humant fedmemodtagelighedsgen og anvendelser deraf DK1504125T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP02291201A EP1362926A1 (en) 2002-05-15 2002-05-15 Human obesity susceptibility gene and uses thereof
EP20020292392 EP1403380A1 (en) 2002-09-27 2002-09-27 Human obesity susceptibility gene and uses thereof
PCT/EP2003/005052 WO2003097683A2 (en) 2002-05-15 2003-05-14 Human obesity susceptibility gene and uses thereof

Publications (1)

Publication Number Publication Date
DK1504125T3 true DK1504125T3 (da) 2009-02-09

Family

ID=29551340

Family Applications (1)

Application Number Title Priority Date Filing Date
DK03730032T DK1504125T3 (da) 2002-05-15 2003-05-14 Humant fedmemodtagelighedsgen og anvendelser deraf

Country Status (9)

Country Link
US (2) US20050123923A1 (da)
EP (3) EP1504125B1 (da)
AT (1) ATE412778T1 (da)
AU (1) AU2003240640B2 (da)
CA (1) CA2484176A1 (da)
DE (1) DE60324414D1 (da)
DK (1) DK1504125T3 (da)
ES (1) ES2314206T3 (da)
WO (1) WO2003097683A2 (da)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2580727A1 (en) 2004-09-17 2006-03-30 Children's Medical Center Corporation Compositions and methods for obesity screening using polymorphisms in npy2r
EP1815027A1 (en) * 2004-11-22 2007-08-08 Integragen Human obesity susceptibility gene encoding potassium ion channels and uses thereof
US20060177847A1 (en) * 2004-12-09 2006-08-10 Perlegen Sciences, Inc. Markers for metabolic syndrome obesity and insulin resistance

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4861719A (en) 1986-04-25 1989-08-29 Fred Hutchinson Cancer Research Center DNA constructs for retrovirus packaging cell lines
US5278056A (en) 1988-02-05 1994-01-11 The Trustees Of Columbia University In The City Of New York Retroviral packaging cell lines and process of using same
US5670488A (en) 1992-12-03 1997-09-23 Genzyme Corporation Adenovirus vector for gene therapy
WO1994019478A1 (en) 1993-02-22 1994-09-01 The Rockefeller University Production of high titer helper-free retroviruses by transient transfection
FR2712812B1 (fr) 1993-11-23 1996-02-09 Centre Nat Rech Scient Composition pour la production de produits thérapeutiques in vivo.
US5516653A (en) * 1993-12-28 1996-05-14 Synaptic Pharmaceutical Corporation DNA encoding a human neuropeptide Y/peptide YY/pancreatic polypeptide receptor (Y4) and uses thereof
EP0791009A4 (en) * 1994-11-07 2003-03-05 Merck & Co Inc MODIFIED NEUROPEPTIDE Y RECEPTOR
IL116816A (en) 1995-01-20 2003-05-29 Rhone Poulenc Rorer Sa Cell for the production of a defective recombinant adenovirus or an adeno-associated virus and the various uses thereof
US6013516A (en) 1995-10-06 2000-01-11 The Salk Institute For Biological Studies Vector and method of use for nucleic acid delivery to non-dividing cells
WO2000030674A1 (en) * 1998-11-26 2000-06-02 Ferring Bv Neuropeptide y y4 agents in the treatment of reproductive disorders
WO2001018250A2 (en) * 1999-09-10 2001-03-15 Whitehead Institute For Biomedical Research Single nucleotide polymorphisms in genes

Also Published As

Publication number Publication date
EP1504125A2 (en) 2005-02-09
AU2003240640B2 (en) 2009-10-22
EP1995331A1 (en) 2008-11-26
CA2484176A1 (en) 2003-11-27
DE60324414D1 (de) 2008-12-11
EP1504125B1 (en) 2008-10-29
ES2314206T3 (es) 2009-03-16
WO2003097683A2 (en) 2003-11-27
WO2003097683A3 (en) 2004-04-01
US20050123923A1 (en) 2005-06-09
EP1997913A1 (en) 2008-12-03
AU2003240640A1 (en) 2003-12-02
US20070154935A1 (en) 2007-07-05
ATE412778T1 (de) 2008-11-15

Similar Documents

Publication Publication Date Title
Carrasquillo et al. Replication of CLU, CR1, and PICALM associations with alzheimer disease
da Fontoura et al. Candidate gene analyses of skeletal variation in malocclusion
Marder et al. Predictors of parkin mutations in early-onset Parkinson disease: the consortium on risk for early-onset Parkinson disease study
Ghani et al. Association of long runs of homozygosity with Alzheimer disease among African American individuals
Fernandez et al. Familial dyskinesia and facial myokymia (FDFM): a novel movement disorder
Ivanova et al. Hereditary spastic paraplegia 3A associated with axonal neuropathy
EP1100547A4 (en) COMPOSITIONS AND METHODS FOR THE TREATMENT AND DIAGNOSIS OF CARDIOVASCULAR DISEASES
Kuo et al. FCGR2A promoter methylation and risks for intravenous immunoglobulin treatment responses in Kawasaki disease
WO2003065984A3 (en) Methods and compositions for treating cardiovascular disease
WO2006003520A3 (en) Human autism predisposition gene encoding a transcription factor and uses thereof
DK1504125T3 (da) Humant fedmemodtagelighedsgen og anvendelser deraf
De Michele et al. Atypical Friedreich ataxia phenotype associated with a novel missense mutation in the X25 gene
WO2001081634A3 (en) Methods and compositions for the diagnosis and treatment of cardiovascular and tumorigenic disease using 4941
WO2001020026A3 (en) POLYMORPHISMS IN THE HUMAN hPXR GENE AND THEIR USE IN DIAGNOSTIC AND THERAPEUTIC APPLICATIONS
DE602005013080D1 (de) Für prkcb1 kodierendes humanes autismus-suszeptibilitätsgen und dessen verwendung
IL179744A0 (en) Human obesity susceptibility gene encoding a potassium voltage-gated channel and uses thereof
WO2005021787A3 (en) Human obesity susceptibility gene and uses thereof
DK1863937T3 (da) Humant autisme-susceptibilitetsgen kodende for et transmembranprotein og anvendelser deraf
Botis et al. Cognitive function in female patients with schizophrenia and metabolic syndrome
WO2005090600A3 (en) Human obesity susceptibility genes encoding peptide hormones and uses thereof
WO1999045112A3 (en) Chromosome 11-linked coronary heart disease susceptibility gene chd1
Martin Substance-abusing adolescents show ethnic and gender differences in psychiatric disorders
Wolthers et al. Common Genetic Variants in Trypsin Regulating Genes Are Associated with AsparAginase-Associated Pancreatitis in Children with Acute Lymphoblastic Leukemia: A Ponte Di Legno Toxicity Working Group Study
Whitfield et al. The Benefits of Chlorine Chemistry in Pharmaceuticals in the United States and Canada
Mardziah et al. Detection of BCR-ABL T315i mutation in imatinib resistant chronic myeloid leukemia patients